Reaction
Rebound Psoriasis reporting signals
As of the last recalculation, Rebound Psoriasis appears in 580 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is SECUKINUMAB (PRR 260.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Secukinumab | 389 | 260.7 | 261.3 |
| Apremilast | 89 | 25.6 | 25.6 |
| Ixekizumab | 11 | 10.9 | 10.9 |